Similar articles

• Contribution of atenolol, bendrofluazide, and hydrallazine to management of severe hypertension.

  Wilcox RG, Mitchell JR. Wilcox RG, et al. Br Med J. 1977 Aug 27;2(6086):547-50. doi: 10.1136/bmj.2.6086.547. Br Med J. 1977. PMID: 329948 Free PMC article. Clinical Trial.
• [Atenelol and bendrofluazide in the treatment of medium and severe hypertension (preliminary report)].

  Braendli B, Bucher HJ, Nager F, Truniger B. Braendli B, et al. Schweiz Med Wochenschr. 1978 Dec 9;108(49):1976-8. Schweiz Med Wochenschr. 1978. PMID: 373099 Clinical Trial. German.
• A comparative study of the efficacy of indapamide and bendrofluazide given in combination with atenolol.

  Zacharias FJ. Zacharias FJ. Postgrad Med J. 1981;57 Suppl 2:51-2. Postgrad Med J. 1981. PMID: 7033947 Clinical Trial.
• Plasma renin concentration and the hypotensive effect of bendrofluazide and of atenolol.

  Fagard R, Amery A, Deplaen JF, Lijnen P, Missotten A. Fagard R, et al. Clin Sci Mol Med Suppl. 1976 Dec;3:215s-217s. doi: 10.1042/cs051215s. Clin Sci Mol Med Suppl. 1976. PMID: 799551 Clinical Trial.
• [Multicenter study of atenolol, combined with hydralazine and bendroflumethiazide in the treatment of essential, mild, and severe, arterial hypertension].

  Ferreira IJ, Escosa L, Casasnovas JA, Barrios SJ, Marcos JM, Pardell H, Navarro A, de la Fuente V. Ferreira IJ, et al. An Med Interna. 1989 Mar;6(3):128-32. An Med Interna. 1989. PMID: 2491186 Clinical Trial. Spanish.